• DeferoxamineB: Precision Iron Chelation and Regulated Cell D

  2026-07-21

  Explore the advanced role of Deferoxamine (DeferoxamineB) as an iron chelator and apoptosis inducer in cancer research. This article provides deep mechanistic insights, unique protocol guidance, and critical analysis of recent metabolic intervention findings.

• Fluorouracil in Solid Tumor Research: Mechanisms and Strateg

  2026-07-21

  Explore the mechanistic underpinnings and strategic use of Fluorouracil (Adrucil) in translational solid tumor research. This article integrates evidence-based protocols, competitive landscape analysis, and visionary guidance for researchers seeking robust, reproducible, and clinically relevant data.

• AM251 as a CB1 Receptor Antagonist: Applied Workflows & Insi

  2026-07-20

  AM251 empowers neuroscientists and metabolic researchers to dissect CB1-mediated pathways with nanomolar precision. This guide distills experimental workflows, troubleshooting strategies, and data-driven tips for maximizing reproducibility and insight when leveraging AM251 from APExBIO.

• Inhibiting β-Catenin/BCL9 to Enhance Tumor Immunotherapy Res

  2026-07-20

  Feng et al. introduce a selective pharmacological approach to disrupt β-catenin/BCL9 interaction, overcoming immune checkpoint blockade resistance by modulating regulatory T cells within the tumor microenvironment. This strategy addresses a key challenge in colon and breast cancer research, promising improved synergy between targeted and immunotherapeutic interventions.

• Toremifene in Prostate Cancer Research: Protocols & Insights

  2026-07-19

  Harness Toremifene’s precision as a selective estrogen-receptor modulator for advanced prostate cancer and hormone-responsive signaling studies. This guide unpacks experimental workflows, troubleshooting strategies, and recent breakthroughs—empowering researchers to optimize reproducibility in estrogen and calcium pathway investigations.

• Docosahexaenoic Acid (DHA): Applied Workflows & Troubleshoot

  2026-07-18

  Docosahexaenoic Acid (DHA) is redefining neuroprotection and anti-inflammatory research with precise, reproducible workflows. This guide delivers actionable protocol enhancements, troubleshooting strategies, and practical application insights to maximize DHA’s translational impact in both bench and clinical models.

• Intra- and Extracellular Activity of Dicloxacillin Against M

  2026-07-17

  This article examines the reference study's systematic comparison of intra- and extracellular activity of dicloxacillin against methicillin-sensitive Staphylococcus aureus (MSSA) using both in vitro and in vivo models. The findings clarify the pharmacodynamic predictors of efficacy and establish evidence-based guidance for translational research on Gram-positive bacterial infection models.

• Deep Learning of USC Mitochondria as an Alzheimer’s Biomarke

  2026-07-17

  This study pioneers a deep learning framework to analyze mitochondrial morphology in live urine-derived stem cells (USCs) as a non-invasive biomarker for Alzheimer’s disease. By distinguishing mitochondrial dynamics in cognitively impaired individuals, the approach offers new potential for early AD detection using accessible patient samples.

• Testosterone Bounce as a Prognostic Biomarker in Degarelix T

  2026-07-16

  A recent multicenter study identifies 'testosterone bounce'—a transient rise in serum testosterone—as a significant predictor of overall and cancer-specific survival in prostate cancer patients treated with the GnRH receptor antagonist Degarelix acetate. This work refines risk stratification beyond PSA monitoring and informs future biomarker-driven therapeutic decisions.

• Enhancing Apoptosis in Pancreatic Cancer via Caspase-8/c-FLI

  2026-07-16

  The referenced study introduces a novel strategy to sensitize pancreatic cancer cells to apoptosis by pharmacologically targeting the caspase-8/c-FLIPL heterodimer and combining this with mitochondrial apoptosis induction using an MCL1 inhibitor. This combinatorial approach enhances death receptor-mediated cell death and provides a promising direction for improving therapeutic efficacy in resistant cancers.

• Neuroligin 1 Loss Drives Repetitive Behaviors via PKC in ASD

  2026-07-15

  This study reveals that loss of Neuroligin 1 in striatal D2-MSNs leads to excessive repetitive behaviors in mice, mediated by hyperactivation of the PKC pathway. The findings clarify how specific synaptic and signaling alterations contribute to autism-like behaviors and highlight PKC as a mechanistic node for future intervention.

• Targeting SCUBE3: Antibody Suppression of Cancer Progression

  2026-07-15

  This study identifies secretory protein SCUBE3 as a key driver of oncogenic signaling and immunosuppressive tumor microenvironments. The development of a neutralizing antibody against SCUBE3 demonstrates potent inhibition of tumor growth and resistance, offering a promising direction for pan-cancer therapy.

• Palmitic acid (Hexadecanoic Acid): Protocol Parameters & Wor

  2026-07-14

  Palmitic acid (SKU N2456) enables reproducible investigation of metabolic disorder pathways, protein palmitoylation, and inflammation signaling in vitro where high-purity, non-aqueous fatty acid delivery is essential. It is not suitable for protocols requiring aqueous solubility or long-term solution stability.

• NHS-Biotin: Precision Biotinylation for Multimeric Protein W

  2026-07-14

  NHS-Biotin (N-hydroxysuccinimido biotin) delivers exceptional versatility for biotinylating antibodies, nanobodies, and proteins, enabling robust labeling and purification. Discover step-by-step protocols, troubleshooting insights, and how the latest peptidisc-assisted clustering expands biotinylation to next-generation protein engineering.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-07-13

  Wang et al. uncover a novel METTL16-SENP3-LTF signaling axis that confers ferroptosis resistance and promotes tumorigenesis in hepatocellular carcinoma (HCC). This mechanistic insight highlights iron metabolic regulation as a therapeutic vulnerability, with implications for targeting ferroptosis in resistant liver cancers.

16358 records 1/1091 page Next 12345 下5页 Last page